Monitoring human growth and development: a continuum from the womb to the classroom - 25/09/15
, Aris T. Papageorghiou, MD a, Ruyan Pang, MD c, Laurent J. Salomon, PhD d, Ana Langer, MD e, Cesar Victora, MD f, Manorama Purwar, MD g, Cameron Chumlea, PhD h, Wu Qingqing, MD i, Sicco A. Scherjon, MD j, Fernando C. Barros, MD f, k, Maria Carvalho, MD l, Douglas G. Altman, DSc m, Francesca Giuliani, MD n, Enrico Bertino, MD n, Yasmin A. Jaffer, MD o, Leila Cheikh Ismail, PhD a, Eric O. Ohuma, MSc a, m, Ann Lambert, PhD a, J. Alison Noble, DPhil b, Michael G. Gravett, MD p, Zulfiqar A. Bhutta, PhD q, Stephen H. Kennedy, MD aAbstract |
A comprehensive set of fully integrated anthropometric measures is needed to evaluate human growth from conception to infancy so that consistent judgments can be made about the appropriateness of fetal and infant growth. At present, there are 2 barriers to this strategy. First, descriptive reference charts, which are derived from local, unselected samples with inadequate methods and poor characterization of their putatively healthy populations, commonly are used rather than prescriptive standards. The use of prescriptive standards is justified by the extensive biologic, genetic, and epidemiologic evidence that skeletal growth is similar from conception to childhood across geographic populations, when health, nutrition, environmental, and health care needs are met. Second, clinicians currently screen fetuses, newborn infants, and infants at all levels of care with a wide range of charts and cutoff points, often with limited appreciation of the underlying population or quality of the study that generated the charts. Adding to the confusion, infants are evaluated after birth with a single prescriptive tool: the World Health Organization Child Growth Standards, which were derived from healthy, breastfed newborn infants, infants, and young children from populations that have been exposed to few growth-restricting factors. The International Fetal and Newborn Growth Consortium for the 21st Century Project addressed these issues by providing international standards for gestational age estimation, first-trimester fetal size, fetal growth, newborn size for gestational age, and postnatal growth of preterm infants, all of which complement the World Health Organization Child Growth Standards conceptually, methodologically, and analytically. Hence, growth and development can now, for the first time, be monitored globally across the vital first 1000 days and all the way to 5 years of age. It is clear that an integrative approach to monitoring growth and development from pregnancy to school age is desirable, scientifically supported, and likely to improve care, referral patterns, and reporting systems. Such integration can be achieved only through the use of international growth standards, especially in increasingly diverse, mixed ancestry populations. Resistance to new scientific developments has been hugely problematic in medicine; however, we are confident that the obstetric and neonatal communities will join their pediatric colleagues worldwide in the adoption of this integrative strategy.
Le texte complet de cet article est disponible en PDF.Key words : continuity of care, growth monitoring, prescriptive standards
| The authors report no conflict of interest. |
Vol 213 - N° 4
P. 494-499 - octobre 2015 Retour au numéro
Article précédent
- Menstrual preconditioning for the prevention of major obstetrical syndromes in polycystic ovary syndrome
- Ivo Brosens, Giuseppe Benagiano
- Pills on the World Wide Web: reducing barriers through technology
- Lori M. Gawron, David K. Turok
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?